84
views
0
recommends
+1 Recommend
0 collections
    3
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prevention of sexually transmitted diseases among visually impaired people: educational text validation Translated title: Prevenção de doenças sexualmente transmissíveis entre pessoas com deficiência visual: validação de texto educativo Translated title: Prevención de enfermedades de trasmisión sexual entre personas con deficiencia visual: validación de texto educativo

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          ABSTRACT Objective: to validate an educational text in the context of Sexually Transmitted Diseases (STD) for visually impaired persons, making it accessible to this population. Method: a validation study, in a virtual environment. Data collection occurred from May to September 2012 by emailing the subjects, and was composed by seven content experts about STDs. Analysis was based on the considerations of the experts about Objectives, Structure and Presentation, and Relevance. Results: on the Objectives and Structure and Presentation blocks, 77 (84.6%) and 48 (85.7%) were fully adequate or appropriate, respectively. In the Relevance block, items 3.2 - Allows transfer and generalization of learning, and 3.5 - Portrays aspects needed to clarify the family, showed bad agreement indices of 0.42 and 0.57, respectively. The analysis was followed by reformulating the text according to the relevant suggestions. Conclusion: the text was validated regarding the content of sexually transmitted diseases. A total of 35 stanzas were removed and nine others included, following the recommendations of the experts.

          Translated abstract

          RESUMO Objetivo: validar texto educativo no contexto das doenças sexualmente transmissíveis para pessoas com deficiência visual para torná-lo acessível a essa população. Método: estudo de validação, em ambiente virtual. Coleta de dados de maio a setembro de 2012, por meio da utilização dos e-mails eletrônicos dos sujeitos, compostos por sete especialistas em conteúdo na temática, através de instrumento próprio. Análise ocorreu com base nas considerações dos especialistas sobre os Objetivos, Estrutura e Apresentação e Relevância. Resultados: nos blocos de Objetivos e Estrutura e Apresentação, 77 (84,6%) e 48 (85,7%) eram totalmente adequados ou adequados, respectivamente. No bloco de Relevância, os itens 3.2 - Permite transferência e generalização da aprendizagem, e 3.5 - Mostra aspectos necessários para informar a família, revelaram índices de concordância ruins de 0,42 e 0,57, respectivamente. Após a análise, o texto foi reformulado de acordo com as sugestões relevantes. Conclusão: o texto foi validado com relação ao conteúdo das Doenças Sexualmente Transmissíveis. Ao total, 35 estrofes foram removidos e outros nove incluídos, seguindo as recomendações dos especialistas.

          Translated abstract

          RESUMEN Objetivo: educativo en el contexto de las enfermedades de trasmisión sexual para personas con deficiencia visual para hacerlo accesible a esa población. Método: un estudio de validación en ambiente virtual. Recolecta de datos de mayo a septiembre de 2012 mediante la utilización de los correos electrónicos de los sujetos, compuestos por siete especialistas en contenido en el tema, a través de instrumento propio. El análisis fue basado en las consideraciones de los especialistas sobre los Objetivos, Estructura y Presentación y Relevancia. Resultados: en los bloques de Objetivos y Estructura y Presentación, 77 (84,6%) y 48 (85,7%) eran totalmente adecuados o adecuados, respectivamente. En el bloque de Relevancia, los ítems 3.2 - Permite transferencia y generalización del aprendizaje, y 3.5 - Muestra aspectos necesarios para informar la familia, revelaron índices de concordancia malos de 0,42 y 0,57, respectivamente. Después del análisis, el texto fue reformulado de acuerdo con las sugestiones relevantes. Conclusión: el texto fue validado respecto al contenido de las enfermedades de trasmisión sexual. Al total, 35 estrofas fueron removidas y otros nueve incluidas, siguiendo las recomendaciones de los especialistas.

          Related collections

          Most cited references64

          • Record: found
          • Abstract: found
          • Article: not found

          The prevalence of hepatitis B virus infection in the United States in the era of vaccination.

          Our objective was to assess trends in the prevalence of hepatitis B virus (HBV) infection in the United States after widespread hepatitis B vaccination. The prevalence of HBV infection and immunity was determined in a representative sample of the US population for the periods 1999-2006 and 1988-1994. National Health and Nutrition Examination Surveys participants 6 years of age were tested for antibody to hepatitis B core antigen (anti-HBc), hepatitis B surface antigen (HBsAg), and antibody to hepatitis B surface antigen (anti-HBs). Prevalence estimates were weighted and age-adjusted. During the period 1999-2006, age-adjusted prevalences of anti-HBc (4.7%) and HBsAg (0.27%) were not statistically different from what they were during 1988-1994 (5.4% and 0.38%, respectively). The prevalence of anti-HBc decreased among persons 6-19 years of age (from 1.9% to 0.6%; P < .01) and 20-49 years of age (from 5.9% to 4.6%; P < .01) but not among persons 50 years of age (7.2% vs 7.7%). During 1999-2006, the prevalence of anti-HBc was higher among non-Hispanic blacks (12.2%) and persons of "Other" race (13.3%) than it was among non-Hispanic whites (2.8%) or Mexican Americans (2.9%), and it was higher among foreign-born participants (12.2%) than it was among US-born participants (3.5%). Prevalence among US-born children 6-19 years of age (0.5%) did not differ by race or ethnicity. Disparities between US-born and foreign-born children were smaller during 1999-1996 (0.5% vs 2.0%) than during 1988-1994 (1.0% vs 12.8%). Among children 6-19 years of age, 56.7% had markers of vaccine-induced immunity. HBV prevalence decreased among US children, which reflected the impact of global and domestic vaccination, but it changed little among adults, and approximately 730,000 US residents (95% confidence interval, 550,000-940,000) are chronically infected.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial.

            Anal cancer remains rare (incidence of about 1·5 per 100,000 women yearly), but rates are increasing in many countries. Human papillomavirus (HPV) 16 and 18 infections cause most cases of anal cancer. We assessed efficacy of an AS04-adjuvanted HPV 16 and HPV 18 vaccine against anal infection with HPV 16, HPV 18, or both (HPV 16/18). Women from Costa Rica were registered between June 28, 2004, and Dec 21, 2005, in a randomised double-blind controlled trial that was designed to assess vaccine efficacy against persistent cervical HPV 16/18 infections and associated precancerous lesions. Eligible women were residents of Guanacaste and selected areas of Puntarenas, Costa Rica, age 18-25 years, in good general health, willing to provide informed consent, and were not pregnant or breastfeeding. Participants were randomly assigned (1:1) to receive an HPV vaccine (Cervarix, GlaxoSmithKline, Rixensart, Belgium) or a control hepatitis A vaccine (modified preparation of Havrix, GlaxoSmithKline, Rixensart, Belgium). Vaccines were administered in three 0·5 mL doses at enrolment, 1 month, and 6 months. Women, selected at the final blinded study visit 4 years after vaccination, provided anal specimens for assessment of vaccine efficacy against anal HPV 16/18 infection. Prevalence of anal HPV 16/18 infections, reported as vaccine efficacy, was the primary endpoint of the study described here. Vaccine efficacy against cervical HPV 16/18 infection in the same women at the 4-year visit was used as a comparator. Analyses were done in a restricted cohort of women who were negative for both cervical HPV 16 and HPV 18 DNA and who were HPV 16 and HPV 18 seronegative before enrolment (HPV naive), and also in the full cohort of women who provided an anal specimen. Investigators were masked to group assignment. This study is registered at ClinicalTrials.gov, number NCT00128661. All women who attended the final blinded study visit and consented to anal specimen collection were included in the analysis (4210 of 6352 eligible women). In the full cohort, vaccine efficacy against prevalent HPV 16/18 infection measured one-time, 4 years post vaccination was lower at the anus (62·0%, 95% CI 47·1-73·1) compared with the cervix (76·4%, 67·0-83·5; p for interaction by anatomical site 0·031). In the restricted cohort, vaccine efficacy against anal HPV 16/18 infection was 83·6% (66·7-92·8), which was similar to vaccine efficacy against cervical HPV 16/18 infection (87·9%, 77·4-94·0). Safety issues were not addressed in the current analysis. Additional safety data will be published later in a separate article. The AS04-adjuvanted vaccine affords strong protection against anal HPV infection, particularly among women more likely to be HPV naive at enrolment. National Cancer Institute with contributions from the National Institutes of Health Office of Research on Women's Health. Vaccine was provided by GlaxoSmithKline Biologicals. Copyright © 2011 Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Syphilis in the modern era: an update for physicians.

              Syphilis is a complex, systemic disease caused by the spirochete Treponema pallidum. Syphilis is most commonly transmitted sexually or congenitally and can involve nearly every organ system. Its clinical progression involves several well-characterized stages: an incubation period, a primary stage, a secondary stage, a latent stage, and a late or tertiary stage. Syphilis during pregnancy is a leading cause of perinatal mortality in sub-Saharan Africa and can cause spontaneous abortion, stillbirth, prematurity, low birth weight, or congenital syphilis. Penicillin is highly effective against syphilis and remains the treatment of choice. This article reviews the epidemiology, clinical features, diagnostic approach, treatment, and prevention of syphilis.
                Bookmark

                Author and article information

                Contributors
                Role: ND
                Role: ND
                Role: ND
                Role: ND
                Role: ND
                Journal
                rlae
                Revista Latino-Americana de Enfermagem
                Rev. Latino-Am. Enfermagem
                Escola de Enfermagem de Ribeirão Preto / Universidade de São Paulo
                1518-8345
                2016
                : 24
                : 0
                : e2775
                Affiliations
                [1 ] Universidade Federal do Ceará Brazil
                [2 ] Universidade Federal do Ceará Brazil
                [3 ] Universidade Federal do Ceará Brazil
                Article
                S0104-11692016000100393
                10.1590/1518-8345.0906.2775
                fb38f478-d476-4688-8ea1-37eb194297a5

                This work is licensed under a Creative Commons Attribution 4.0 International License.

                History
                Product

                SciELO RevOdonto

                Self URI (journal page): http://www.scielo.br/scielo.php?script=sci_serial&pid=0104-1169&lng=en
                Categories
                NURSING

                Pessoas com Deficiência Visual,Doenças Sexualmente Transmissíveis,Equipamentos de Autoajuda,Personas con Daño Visual,Enfermedades de Transmisión Sexual,Dispositivos de Autoayuda,Visually Impaired Persons,Sexually Transmitted Diseases,Self-Help Devices

                Comments

                Comment on this article

                scite_

                Similar content130

                Cited by3

                Most referenced authors208